191 related articles for article (PubMed ID: 22924088)
1. Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.
Dugger BN; Serrano GE; Sue LI; Walker DG; Adler CH; Shill HA; Sabbagh MN; Caviness JN; Hidalgo J; Saxon-Labelle M; Chiarolanza G; Mariner M; Henry-Watson J; Beach TG;
J Parkinsons Dis; 2012 Jan; 2(1):57-65. PubMed ID: 22924088
[TBL] [Abstract][Full Text] [Related]
2. Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
Beach TG; Sue LI; Walker DG; Sabbagh MN; Serrano G; Dugger BN; Mariner M; Yantos K; Henry-Watson J; Chiarolanza G; Hidalgo JA; Souders L
J Alzheimers Dis; 2012; 28(4):869-76. PubMed ID: 22112552
[TBL] [Abstract][Full Text] [Related]
3. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.
Jellinger KA
J Neural Transm (Vienna); 2021 May; 128(5):687-699. PubMed ID: 33928445
[TBL] [Abstract][Full Text] [Related]
4. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
[TBL] [Abstract][Full Text] [Related]
5. Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.
Beach TG; Thal DR; Zanette M; Smith A; Buckley C
J Alzheimers Dis; 2016 Mar; 52(3):863-73. PubMed ID: 27031469
[TBL] [Abstract][Full Text] [Related]
6. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
7. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
9. Cerebral amyloid angiopathy in Lewy body disease.
Jellinger KA; Attems J
J Neural Transm (Vienna); 2008; 115(3):473-82. PubMed ID: 18301958
[TBL] [Abstract][Full Text] [Related]
10. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
11. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
12. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
Tsuboi Y; Dickson DW
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
[TBL] [Abstract][Full Text] [Related]
13. Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies.
Hepp DH; Vergoossen DL; Huisman E; Lemstra AW; ; Berendse HW; Rozemuller AJ; Foncke EM; van de Berg WD
J Neuropathol Exp Neurol; 2016 Oct; 75(10):936-945. PubMed ID: 27516115
[TBL] [Abstract][Full Text] [Related]
14. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
15. Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies.
Smith C; Malek N; Grosset K; Cullen B; Gentleman S; Grosset DG
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1234-1243. PubMed ID: 31444276
[TBL] [Abstract][Full Text] [Related]
16. Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes.
Kalaitzakis ME; Walls AJ; Pearce RK; Gentleman SM
Neurobiol Dis; 2011 Feb; 41(2):377-84. PubMed ID: 20951207
[TBL] [Abstract][Full Text] [Related]
17. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
[TBL] [Abstract][Full Text] [Related]
19. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.
Nagy Z; Esiri MM; Jobst KA; Morris JH; King EM; McDonald B; Litchfield S; Smith A; Barnetson L; Smith AD
Dementia; 1995; 6(1):21-31. PubMed ID: 7728216
[TBL] [Abstract][Full Text] [Related]
20. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
